MedPath

A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection

Phase 2
Completed
Conditions
HIV Infections
Registration Number
NCT00002086
Lead Sponsor
Glaxo Wellcome
Brief Summary

Primary: To determine whether the combination of zidovudine/zalcitabine/interferon alfa-n1 (Retrovir/HIVID/Wellferon) can produce complete responses (i.e., CD4 counts return to \>= 800 cells/mm3 for more than 24 weeks) in patients with virus sensitive to all three agents. To determine the antiviral effect of the combination therapies as evidenced by measures of quantitative viral load performed at select study centers only.

Secondary: To determine the effectiveness of Retrovir/HIVID and Retrovir/HIVID/Wellferon in maintaining or increasing CD4 counts and preventing disease progression as evidenced by the development of an AIDS-defining indicator disease. To determine the effect of these regimens on secondary measures of clinical status (e.g., performance score, weight change, and secondary infections) and on measures of virologic activity such as serum p24 antigen. To assess the safety and tolerance of these regimens.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
256
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (13)

Univ of Kansas School of Medicine

🇺🇸

Wichita, Kansas, United States

Marin County Specialty Clinic

🇺🇸

San Rafael, California, United States

Stratogen of South Florida

🇺🇸

Miami Beach, Florida, United States

Portland Veterans Adm Med Ctr / Rsch & Education Grp

🇺🇸

Portland, Oregon, United States

Univ of Utah School of Medicine

🇺🇸

Salt Lake City, Utah, United States

Univ of South Florida

🇺🇸

Tampa, Florida, United States

ViRx Inc

🇺🇸

San Francisco, California, United States

Univ of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

Infectious Diseases Research Clinic / Indiana Univ Hosp

🇺🇸

Indianapolis, Indiana, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

Vanderbilt School of Medicine

🇺🇸

Nashville, Tennessee, United States

Georgetown Univ Med Ctr

🇺🇸

Washington, District of Columbia, United States

North Shore Univ Hosp / Div of Infectious Diseases

🇺🇸

Manhasset, New York, United States

© Copyright 2025. All Rights Reserved by MedPath